Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis.
about
Expression of inducible nitric oxide synthase in human granulomas and histiocytic reactions1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell lineReactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogensRole of oxidants in microbial pathophysiologyThe emerging role of gasotransmitters in the pathogenesis of tuberculosisInnate Immunity Holding the Flanks until Reinforced by Adaptive Immunity against Mycobacterium tuberculosis InfectionMechanisms of Control of Mycobacterium tuberculosis by NK Cells: Role of GlutathioneInnate Immune Defenses in Human Tuberculosis: An Overview of the Interactions between Mycobacterium tuberculosis and Innate Immune CellsInnate immune gene polymorphisms in tuberculosisRedox homeostasis in mycobacteria: the key to tuberculosis control?MR1-restricted mucosal associated invariant T (MAIT) cells in the immune response to Mycobacterium tuberculosisPeroxynitrite, a potent macrophage-derived oxidizing cytotoxin to combat invading pathogensThe Role of Nitric Oxide in Mycobacterial InfectionsSpotlights on immunological effects of reactive nitrogen species: When inflammation says nitric oxideTB drug development: immunology at the tableNitric oxide synthases: regulation and functionEffect of oestrogen on Mycobacterium avium complex pulmonary infection in miceModulation of Mycobacterium bovis-specific responses of bovine peripheral blood mononuclear cells by 1,25-dihydroxyvitamin D(3)"Of mice and men": arginine metabolism in macrophagesImmune markers measured before treatment predict outcome of intensive phase tuberculosis therapyHypoxia induces an immunodominant target of tuberculosis specific T cells absent from common BCG vaccinesResistance to first-line anti-TB drugs is associated with reduced nitric oxide susceptibility in Mycobacterium tuberculosisDevS, a heme-containing two-component oxygen sensor of Mycobacterium tuberculosisMycobacterium tuberculosis expresses methionine sulphoxide reductases A and B that protect from killing by nitrite and hypochloriteResponse to reactive nitrogen intermediates in Mycobacterium tuberculosis: induction of the 16-kilodalton alpha-crystallin homolog by exposure to nitric oxide donorsMycobacteria counteract a TLR-mediated nitrosative defense mechanism in a zebrafish infection modelIdentification of nitric oxide synthase as a protective locus against tuberculosisNitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus.noxR3, a novel gene from Mycobacterium tuberculosis, protects Salmonella typhimurium from nitrosative and oxidative stress.Intracellular growth of Mycobacterium tuberculosis after macrophage cell death leads to serial killing of host cells.Nitric oxide and nitrotyrosine in the lungs of patients with acute respiratory distress syndrome.Resistance of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis to nitric oxide correlates with disease severity in Tegumentary Leishmaniasis.Probing host pathogen cross-talk by transcriptional profiling of both Mycobacterium tuberculosis and infected human dendritic cells and macrophages.Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responsesImmunomodulation with recombinant interferon-gamma1b in pulmonary tuberculosis.Nitric Oxide Synthesis is Modulated by 1,25-Dihydroxyvitamin D3 and Interferon-gamma in Human Macrophages after Mycobacterial Infection.Nitric oxide and infectious diseases.Inhibition of influenza virus replication by nitric oxideComparative and prospective study of different immune parameters in healthy subjects at risk for tuberculosis and in tuberculosis patients.Immunomodulation of pneumococcal pulmonary infection with N(G)-monomethyl-L-arginine.
P2860
Q22008706-55853DB4-2B23-4A22-AB42-D9858099939EQ24523233-E39BF153-24D9-40CF-AEC4-1D42081AA5DDQ24630289-BF6DF5C1-A84E-4C10-8B84-273F4B5D2F28Q24683780-274D141C-1C8D-4D87-9D89-B06F673AA50DQ26744038-688E6FB5-4B88-4878-8688-373B30BDEBC6Q26751060-6D865E6E-B768-4FDC-B39D-AE3F906E2880Q26779214-6C97E214-37E5-472E-90C4-4EB5B58DC740Q26799901-4635EF02-06FF-45F1-886E-DD61CD6AE488Q27000486-F2E9AACA-B5CC-4597-B18E-77DA35EEDAFCQ27012879-82EBADA7-C52E-4514-8A46-C714F6AC3829Q27016137-879248EB-4A19-4049-9127-7984D2959672Q27025454-24A66FBE-ACE1-4028-8B8B-DD165657232BQ27490787-27277920-6B88-4F08-929D-819D791CA6B7Q27694770-B2DDE847-3ECE-470B-BE5D-982078C2BC44Q28083600-87DD9E14-A4BF-45DE-ABD0-2C7673547111Q28247092-16491163-52F1-4A8B-84E7-92839AAA4DA3Q28362317-E20D8B77-6B03-4161-9C4E-09997D4C66EDQ28362977-156CFF60-0B43-4896-BEB2-A89969B67FB4Q28395476-70440846-EA41-4335-9642-E3FD27EE3BCFQ28396491-5E64B486-19BC-4B5B-8F9F-41291361A1EEQ28476626-4CAADFD3-BB37-4C97-AC54-FE6B7BA9CAC8Q28480924-CAA15395-C495-4AF9-B1AC-1DC74668F698Q28486549-A2441662-0AAC-4DBD-AB1D-34432EBF0C11Q28486777-A589DC80-0118-46AB-A939-CF6AEC7199CFQ28487034-582F892F-8F01-4585-9E11-5D59C5D483E6Q28540070-5EE4E982-27E1-4EA4-8AD8-8C4E3881B12CQ29620411-16DAFF18-DCBC-42EC-805F-D6C751C1F411Q30233119-EFB580A3-18AD-4076-B0BC-F2A7D1B2E8CBQ30720627-1B9CE713-CFCD-4323-8B5C-6C4D4C7082C6Q30839454-93E43C4C-508D-466B-A4DC-7CA6E8E3D4D0Q31941514-771FEFD9-578E-4FE2-A311-725874620C66Q33275038-EAE1C68A-3AF8-4A3D-9A28-FD769C8C6AB5Q33312964-4DF1EE73-98B3-4708-A0F7-080AF8E03D50Q33463449-C783E552-7A8E-4782-9F9F-DD87F1CFA34CQ33503248-7FD60BBE-8F21-476B-88CC-92C3A7ADE71BQ33631976-297916D4-AD5A-452C-AD32-B4558ED2913DQ33734476-F0EF9F4F-9B4A-4DB8-9203-A3CB520988F0Q33821697-AAC19A7A-3750-44EF-8895-2D52EB678F8CQ33942054-028E8F19-E194-46E4-BB5A-1E0D4B18D9D5Q33977703-359323A4-364E-4492-A1EF-D219FB38C0B6
P2860
Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Inducible nitric oxide synthas ...... om patients with tuberculosis.
@ast
Inducible nitric oxide synthas ...... om patients with tuberculosis.
@en
type
label
Inducible nitric oxide synthas ...... om patients with tuberculosis.
@ast
Inducible nitric oxide synthas ...... om patients with tuberculosis.
@en
prefLabel
Inducible nitric oxide synthas ...... om patients with tuberculosis.
@ast
Inducible nitric oxide synthas ...... om patients with tuberculosis.
@en
P2093
P2860
P356
P1476
Inducible nitric oxide synthas ...... om patients with tuberculosis.
@en
P2093
C Linhares
J Calaycay
J R Lapa e Silva
J R Weidner
M da G Bonecini-Almeida
P2860
P304
P356
10.1084/JEM.183.5.2293
P407
P577
1996-05-01T00:00:00Z